In the medical device market, payers at all levels are looking at the costs and benefits to justify investment in new medical technologies and the new procedures in which they might be used. Globally, payers are assessing technologies on the grounds of clinical effectiveness, cost effectiveness, cost utility and cost benefit. As the industry moves towards HTA and value demonstration as a requirement for medical devices, value demonstration will increasingly be a fact that all medical device companies seeking to gain reimbursement and approval from payers and regulatory bodies need to take into consideration. This conference walks stakeholders through what payers are looking for, as well as strategies to better achieve device and diagnostic reimbursement and approval.

Explore timely and focused content surrounding:

• Strategic coding decisions to optimize global reimbursement, patient access and patient safety
• CPT coding assessments and interactions with Medicare
• Ensuring appropriate and accurate evidence to have a proactive and constructive clearance and approval plan
• Risk sharing to increase stakeholder reimbursement incentives
• Health economics optimization strategies to drive market access
• Increased reimbursement opportunities in emerging markets
• Implications of the Affordable Care Act on reimbursement
• ACO healthcare reform initiatives
• Bundled Payments for Care Improvement